e-learning
resources
Berlin 2008
Monday, 06.10.2008
Basic science in asthma and COPD II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tc2 response at the onset of COPD exacerbations
S. Lazarou, D. Makris, M. Alexandrakis, T. Kourelis, K. Bartziokas, D. Kyriakou, K. Gourgoulianis (Larissa, Crete, Greece)
Source:
Annual Congress 2008 - Basic science in asthma and COPD II
Session:
Basic science in asthma and COPD II
Session type:
Thematic Poster Session
Number:
1979
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Lazarou, D. Makris, M. Alexandrakis, T. Kourelis, K. Bartziokas, D. Kyriakou, K. Gourgoulianis (Larissa, Crete, Greece). Tc2 response at the onset of COPD exacerbations. Eur Respir J 2008; 32: Suppl. 52, 1979
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Gamma/delta T cells regulate airways disease during rhinovirus-induced asthma exacerbations
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
T regulatory cells decrease before asthma exacerbations
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
The character of COPD exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 34s
Year: 2006
Variability in eosinophil levels at start of severe exacerbations of COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
Change in inflammation during COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 15s
Year: 2005
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
The influence of smoking and the lack of response to prednisolone on tissue-derived T-cells in COPD and severe asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 23s
Year: 2005
Sputum lymphocytes predict the severity of late asthmatic response in asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 227s
Year: 2004
COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Source: Eur Respir J 2013; 41: 993-995
Year: 2013
IL-18 in infectious exacerbations of COPD
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Airway resistance correlates with the frequency of exacerbation in patient with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Variability in exacerbation frequency in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept